MONTVALE, N.J., Aug. 6 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. announced today that it will report its second quarter 2008 financial results on Wednesday, August 13, 2008 before the U.S. financial markets open. Management will provide a Company update and discuss the second quarter results during a conference call the same day, at 9:00 a.m. EDT.
An audio replay of the conference call will be available from 11:00 a.m. EDT on Wednesday, August 13, 2008, until Wednesday, August 20, 2008. To access the replay, please dial 888.286.8010 (U.S.) or 617.801.6888 (international) and enter pass code number 27666214. An audio replay of the conference call will also be available under the "Investors" section of the Company's website during the same period.
About Memory Pharmaceuticals
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders, many of which exhibit significant impairment of memory and other cognitive functions, including Alzheimer's disease and schizophrenia. For additional information, please visit our website at http://www.memorypharma.com.
CONTACT: Jzaneen Lalani, General Counsel of Memory Pharmaceuticals Corp.,
+1-201-802-7249; or Laura Perry of LMP Investor Relations Inc.,
+1-646-719-1055, for Memory Pharmaceuticals Corp.
Web site: http://www.memorypharma.com/
